Recombinant antigen immunoassay for the diagnosis of syphilis

C - Chemistry – Metallurgy – 07 – H

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07H 21/04 (2006.01) C07K 14/44 (2006.01) C07K 19/00 (2006.01) C12N 1/20 (2006.01) C12N 15/09 (2006.01) G01N 33/532 (2006.01) G01N 33/558 (2006.01) G01N 33/569 (2006.01) G01N 33/571 (2006.01)

Patent

CA 2280296

A method for detecting anti-Treponema pallidum antibody and diagnosing syphilis has been provided. Fusion protein antigens from the fusion of a peptide sequence having an amino acid sequence encoded by the nucleic acid sequence of SEQ. ID. No. 4 to Treponema pallidum membrane proteins are used as antigens in immunoassay of test samples for the presence of anti-Treponema pallidum membrane protein antibodies. A test kit for diagnosing syphilis is also provided comprising a container having therein the fusion protein antigens.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Recombinant antigen immunoassay for the diagnosis of syphilis does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Recombinant antigen immunoassay for the diagnosis of syphilis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Recombinant antigen immunoassay for the diagnosis of syphilis will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1721765

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.